Navdeep Pal

Navdeep Pal

Genentech, Inc - South San Francisco / United States
Natural Sciences / Mathematical Sciences
AD Scientific Index ID: 4484152
-
person_outline Navdeep Pal's MOST POPULAR ARTICLES
1-) Evaluating eligibility criteria of oncology trials using real-world data and AIR Liu, S Rizzo, S Whipple, N Pal, AL Pineda, M Lu, B Arnieri, Y Lu, ...Nature 592 (7855), 629-633, 20211932021
2-) Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine deviceN Pal, RR Broaddus, DL Urbauer, N Balakrishnan, A Milbourne, ...Obstetrics & Gynecology 131 (1), 109-116, 20181902018
3-) Overall survival after pelvic exenteration for gynecologic malignancySN Westin, V Rallapalli, B Fellman, DL Urbauer, N Pal, MM Frumovitz, ...Gynecologic oncology 134 (3), 546-551, 20141022014
4-) Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancerSN Westin, B Fellman, CC Sun, RR Broaddus, ML Woodall, N Pal, ...American journal of obstetrics and gynecology 224 (2), 191. e1-191. e15, 2021952021
5-) Effectiveness of PD-(L) 1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD …M Pérol, E Felip, U Dafni, L Polito, N Pal, Z Tsourti, TGN Ton, D Merritt, ...Annals of Oncology 33 (5), 511-521, 2022692022